Page 14 - Exact Sciences News Today

Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.

Biondo Investment Advisors LLC increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares […]

Biondo Investment Advisors LLC boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares during the […]

Van ECK Associates Corp lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.9% during the third quarter, HoldingsChannel.com reports. The fund owned 149,468 shares of the medical research company’s stock after selling 16,345 shares during the period. Van ECK Associates Corp’s holdings in Exact Sciences were worth $10,197,000 as of its […]

Swiss National Bank trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The fund owned 580,280 shares of the medical research company’s stock after selling 63,200 shares during the quarter. Swiss National Bank’s holdings in Exact Sciences were worth $39,587,000 at the end of the […]

Artisan Partners Limited Partnership boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,961,514 shares of the medical research company’s stock after purchasing an additional 418,770 shares […]

This company hasn't performed well in the past 12 months.

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

A top-2% portfolio manager who engineered a 59% gain in 2023 shared her investing philosophy and strategy, plus nine stocks worth buying now.

Blueshift Asset Management LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,887 shares of the medical research company’s stock, valued at approximately $402,000. Other […]